高气道-血管容积比与视觉支气管扩张与慢阻肺急性加重相关
本研究基于两个队列(原始队列N=96,验证队列N=130),探讨慢阻肺患者CT测得的气道与肺血管容积比(AVR)与急性加重的关系。结果显示高AVR组至首次急性加重时间更短,且该关联独立于视觉支气管扩张评分(mReiff)和肺动脉/主动脉直径比(PA/Ao)。AVR可能作为慢阻肺急性加重的新型CT预测指标。
要点
- 高AVR与慢阻肺患者至首次急性加重时间缩短显著相关。
- AVR的预测价值独立于mReiff评分和PA/Ao。
- 肺容积校正后的气道或血管容积与急性加重时间无相关性。
核心结论
- 高AVR与慢阻肺患者至首次急性加重时间缩短相关,且独立于mReiff评分和PA/Ao,提示AVR是新型CT预测指标。
研究设计与样本
- 研究纳入北海道慢阻肺队列(原始队列N=96)和京都大学队列(验证队列N=130),随访5年。
- 评估CT衍生的气道与血管指标、mReiff评分及PA/Ao,采用Kaplan-Meier法和多变量Cox模型分析。
主要发现
- 高AVR组(最高四分位)至首次急性加重时间短于低AVR组(其他四分位),在全部患者及无视觉支气管扩张患者中均如此。
- 高AVR与急性加重显著相关:原始队列HR 3.85(95%CI 1.17-12.6),验证队列HR 2.01(95%CI 1.15-3.52)。
- 肺容积校正后的气道或血管容积与至首次急性加重时间无相关性。
关键数值与推荐
- 高AVR定义为最高四分位,低AVR为其他四分位。
- mReiff评分用于视觉评估支气管扩张,PA/Ao为肺动脉直径与主动脉直径比值。
临床怎么用
- AVR可作为慢阻肺急性加重的CT预测指标,补充mReiff评分和PA/Ao的信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The effects of the volume mismatch between the airway and lung vasculature on exacerbation in chronic obstructive pulmonary disease (COPD) is uncertain. We aimed to examine the association between an increased volume ratio of the airway to lung blood vessels (AVR) and exacerbations, regardless of visually assessed bronchiectasis (modified Reiff [mReiff] score) and extrapulmonary vasculature on computed tomography (CT), in patients with COPD during a 5-year follow-up period. METHODS: Participants were recruited from the Hokkaido COPD Cohort Study (original, N = 96) and Kyoto University cohort (validation, N = 130). CT-derived indices of the airway and vasculature, mReiff scores, and ratio of pulmonary artery diameter to aorta diameter (PA/Ao) were evaluated. The Kaplan-Meier method with log-rank tests was used to compare the high (highest quartile) and low (other quartiles) groups, while multivariable Cox proportional hazards models explored the factors associated with the time to first exacerbation. RESULTS: The high AVR group showed a shorter time to first exacerbation than the low AVR group in analyses of both all patients and those without visual bronchiectasis. High AVR was significantly associated with exacerbations [Hazard ratio [95% confidence interval]: original, 3.85 [1.17, 12.6]; validation, 2.01 [1.15, 3.52]), irrespective of mReiff scores and PA/Ao in all patients. The lung-volume-corrected airway or blood vessel volumes did not correlate with the time to first exacerbation. CONCLUSION: High AVR was associated with a shorter time to first exacerbation, complementary to mReiff score and PA/Ao, suggesting that AVR is a novel CT-derived predictor of exacerbation in COPD.
引用
- Wakazono, Shimizu, Tanabe, et al. High Airway-To-Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in COPD. Respirology. 2025. PMID: 40887770. doi:10.1111/resp.70114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。